UFF
REGN icon

USA Financial Formulas’s Regeneron Pharmaceuticals REGN Stock Holding History

USA Financial Formulas’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,457
Closed -$1.13M – 510
2026
Q1 		$1.13M Buy
+1,457
New +$1.12M 0.21% 27
2024
Q3 		– Sell
-910
Closed -$956K – 354
2024
Q2 		$956K Buy
910
+58
+7% +$56.2K 0.16% 79
2024
Q1 		$820K Buy
+852
New +$810K 0.13% 86
2023
Q4 		– Sell
-2,695
Closed -$2.22M – 502
2023
Q3 		$2.22M Sell
2,695
-17
-0.6% -$13.4K 3.32% 4
2023
Q2 		$1.95M Sell
2,712
-1,276
-32% -$984K 2.99% 7
2023
Q1 		$3.28M Buy
+3,988
New +$3.01M 5.31% 4
2022
Q3 		$1K Hold
1
– – ﹤0.01% 269
2022
Q2 		$1K Hold
1
– – ﹤0.01% 295
2022
Q1 		$1K Sell
1
-2,618
-100% -$1.66M ﹤0.01% 327
2021
Q4 		$1.65M Buy
2,619
+2,613
+43,550% +$1.61M 1.42% 16
2021
Q3 		$4K Buy
+6
New +$3.73K ﹤0.01% 285
2020
Q4 		– Sell
-4,304
Closed -$2.41M – 400
2020
Q3 		$2.41M Sell
4,304
-2,982
-41% -$1.81M 1.82% 18
2020
Q2 		$4.54M Sell
7,286
-174
-2% -$98.8K 3.38% 5
2020
Q1 		$3.64M Buy
+7,460
New +$3.08M 2.32% 6
2019
Q3 		– Sell
-16,517
Closed -$6.78M – 252
2019
Q2 		$6.78M Buy
16,517
+3,587
+28% +$1.19M 3.4% 13
2019
Q1 		$5.31M Buy
12,930
+11,705
+956% +$4.82M 3.34% 15
2018
Q4 		$495K Buy
+1,225
New +$448K 0.12% 125
2018
Q3 		– Sell
-1,143
Closed -$394K – 374
2018
Q2 		$394K Sell
1,143
-9
-0.8% -$2.81K 0.1% 187
2018
Q1 		$397K Buy
+1,152
New +$401K 0.1% 185
2017
Q4 		– Sell
-8,030
Closed -$3.59M – 325
2017
Q3 		$3.59M Buy
+8,030
New +$3.82M 0.86% 36
2015
Q4 		– Sell
-13,895
Closed -$6.46M – 121
2015
Q3 		$6.46M Buy
+13,895
New +$7.46M 4.19% 9

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

USA Financial Formulas's REGN Position: Q2 2026 in Review

USA Financial Formulas sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 1,457 shares — an estimated $1.13M sold.

USA Financial Formulas first reported a position in REGN in Q3 2015 and held it in 21 quarters. The position peaked at $6.78M in Q2 2019. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • USA Financial Formulas reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • USA Financial Formulas sold 1,457 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • USA Financial Formulas first reported a position in Regeneron Pharmaceuticals in Q3 2015 and held it in 21 quarters.
  • USA Financial Formulas's Regeneron Pharmaceuticals position peaked at $6.78M in Q2 2019.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.